DekaBank Deutsche Girozentrale
TBIO

DekaBank Deutsche Girozentrale’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-69,300
Closed -$1.78M – 1445
2021
Q2 		$1.78M Hold
69,300
– – 0.01% 751
2021
Q1 		$1.11M Buy
69,300
+6,000
+9% +$137K ﹤0.01% 874
2020
Q4 		$1.23M Buy
63,300
+18,800
+42% +$336K ﹤0.01% 801
2020
Q3 		$606K Buy
+44,500
New +$686K ﹤0.01% 890

DekaBank Deutsche Girozentrale's TBIO Position: Q3 2021 in Review

DekaBank Deutsche Girozentrale sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 69,300 shares — an estimated $1.78M sold.

DekaBank Deutsche Girozentrale first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $1.78M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 69,300 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.78M.
  • DekaBank Deutsche Girozentrale first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Translate Bio, Inc. Common Stock position peaked at $1.78M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2021, filed 22 Oct 2021.